Hi all,
I am using edgeR flow to get gene lists of multifactorial experiment. I have 6 conditions with 3 samples per each. The problem is some of the gene lists I got end at FDR much less than what I entered and so I did not get the whole gene list. For example, the upregulated genes were completely missing in some lists. I tried increasing the number of genes the program gives using the
< gene_table<-topTags(lrt, n=40000)
but did not help. Then I tried very restreignent FDR as follow
< DE<-tp$table[tp$table$FDR<0.000001,]$GeneID
But again did not help. The last gene in one of my lists was with
Symbol Chr logFC logCPM LR PValue FDR
Hpx 7 -7.186931303 13.83923493 57.6010426 3.21E-014 3.23E-014
Any help would be appreciated!
Unconfigured Ad
Collapse
X
-
Just because a read aligns to the genome doesn't mean that it aligned to a gene. Perhaps it came from an intron or an intergenic region (e.g., due to transcriptional noise).
Leave a comment:
-
Hi all,
I mapped my RNA-seq reads using edgeR and got around 90% of mapping, but when I entered the feature count commands I got only 70% successfully assigned reads. Does any one have an idea?
Note: I have 18 samples, 3 per group. I did single end read sequencing.
Any help would be appreciated
Leave a comment:
-
On a similar note - I am trying to perform differential expression contrasts for 2 different populations - one resistant to a given drug and one wild type (i.e. sensitive). Within each population, I have samples that were treated at just one given concentration of the drug, and samples that were treated with a drug vehicle (control).
So the basic study design for this experiment is :
Population A (resistant):Treatment (Y) vs Control (X)
Population B (wild type): Treatment (Y) vs Control (X)
In addition to population and treatment variables, I also have to adjust for a very strong batch effect (3 batches).
So the formula for my design matrix at the moment is:
~ Batch + Population + Treatment + Population:Treatment
and the resulting design matrix looks like so:
(Intercept) Batch2 Batch3 PopulationB TreatmentY PopulationB:TreatmentY
Sample_1 1 0 0 0 0 0
Sample_2 1 0 0 0 0 0
Sample_3 1 0 0 0 0 0
Sample_4 1 1 0 0 0 0
Sample_5 1 1 0 0 0 0
Sample_6 1 0 0 0 1 0
Sample_7 1 0 0 0 1 0
Sample_8 1 0 0 0 1 0
Sample_9 1 1 0 0 1 0
Sample_10 1 1 0 0 1 0
Sample_11 1 1 0 1 0 0
Sample_12 1 1 0 1 0 0
Sample_13 1 0 1 1 0 0
Sample_14 1 0 1 1 0 0
Sample_15 1 0 1 1 0 0
Sample_16 1 1 0 1 1 1
Sample_17 1 1 0 1 1 1
Sample_18 1 0 1 1 1 1
Sample_19 1 0 1 1 1 1
Sample_20 1 0 1 1 1 1
What I don't understand is given this complete linear model formula, how do I specify contrasts (both edgeR and DESEq) to compare the two treatment methods WITHIN each population?
i.e. I want to test the effect of treatment separately for population A and for population B, adjusting for Batch effect, using this complete model.
Specifying coef=4 would give me the overall difference in expression between the two populations and specifying coef=5 will give me the overall difference in expression between the two treatment methods, but that is less interesting a question given my study design
Any help would be greatly appreciated
Regards
Leave a comment:
-
This question has since been answered on the Bioconductor mailing list:
Leave a comment:
-
EdgeR: Contrasts for both within and between subject comparison
I have two sets of samples, one set being sensitive to a compound treatment, the other resistant. For each group I have patient samples that were left untreated, treated 2h with a compound and 24h with a compound.
I am trying to do resistant vs sensitive comparisons on the data using edgeR. The manual has an example of a comparison both between and within subjects in chapter 3.5 which to me applies 1:1 on my design.
Following the manual, I have set up the following design
design = model.matrix(~resist+resist:sub+resist:treat)
(Intercept) resistY resistN:sub2 resistY:sub2 resistN:sub3 resistY:sub3
1 1 0 0 0 0 0
2 1 0 0 0 0 0
3 1 0 0 0 0 0
4 1 0 1 0 0 0
5 1 0 1 0 0 0
6 1 0 1 0 0 0
7 1 0 0 0 1 0
8 1 0 0 0 1 0
9 1 0 0 0 1 0
10 1 1 0 0 0 0
11 1 1 0 0 0 0
12 1 1 0 0 0 0
13 1 1 0 1 0 0
14 1 1 0 1 0 0
15 1 1 0 1 0 0
16 1 1 0 0 0 1
17 1 1 0 0 0 1
18 1 1 0 0 0 1
resistN:treat24h resistY:treat24h resistN:treat2h resistY:treat2h
1 0 0 0 0
2 0 0 1 0
3 1 0 0 0
4 0 0 0 0
5 0 0 1 0
6 1 0 0 0
7 0 0 0 0
8 0 0 1 0
9 1 0 0 0
10 0 0 0 0
11 0 0 0 1
12 0 1 0 0
13 0 0 0 0
14 0 0 0 1
15 0 1 0 0
16 0 0 0 0
17 0 0 0 1
18 0 1 0 0
Now I understand that with the contrasts c(0,0,0,0,0,0,0,0,-1,1) and c(0,0,0,0,0,0,-1,1,0,0) you can test for differentially expressed genes between resistant and sensitive cells after 2h and 24h treatment, respectively.
What is unclear to me is for example how to test for differentially expressed genes between resistant and sensitive cells in the control?
It cannot be c(0,1,0,0,0,0,0,0,0,0), since that would give me differentially expressed genes between resistant and sensitive cells in any state right?
The only workaround I have come up so far is to relevel the treatment factors and take treat2h as base level in order to be able to have now the control in the contrast in its position. But I tried it and this changes the outcome of the treat24h contrast, so apparently there's something I'm missing.
Does anyone have any experience on that? Any help would be greatly appreciated...
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
49 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
46 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
46 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: